Ukraine registers Oxford/AstraZeneca vaccine for emergency use
News Line
Ukraine reports 5,276 new COVID-19 cases Zelensky: Every third Ukrainian considers road construction one of greatest achievements of 2021 Ukraine ready to implement Minsk agreements, but Russia's desire needed - Yermak Michel: EU unanimously agree to roll over economic sanctions against Russia Actions by Ukraine's partners will help prevent worst-case scenario - Zelensky COVID-19 in Ukraine: Health officials confirm 8,899 daily cases as of Dec 17 Macron tells Zelensky he declared support for Ukraine in call with Putin Zelensky, Scholz discuss gas transit through Ukraine after 2024 Ukraine ready for any format of talks with Russia - Zelensky Ukraine’s only journalist in Russia facing extremism charges - lawyer PM Shmyhal: First two applications for investment projects worth $96 million filed Zelensky, PM of Italy discuss security situation around Ukraine President signs off State Budget 2022 London considering all options for responding to Russia's aggression against Ukraine Putin, Biden to hold another round of talks Some 260,000 Ukrainians “victims of human trafficking” over 30 years - prosecutor general Ukraine plans to create center to protect energy infrastructure from cyber attacks No clear idea so far when Normandy Four top diplomats set to meet - German Ambassador Ukraine receives EUR 600M in macro-financial assistance from EU Zelensky holds phone conversation with PM of Israel Ukraine sets new daily COVID vaccination record MFA: European Union has not yet removed Ukraine from list of safe countries Kyiv records 1,023 new COVID-19 cases, 29 deaths G7 ambassadors welcome adoption of law on NABU status Ukraine can increase Covid vaccination rates to 1.5M a week – Liashko

Ukraine has registered the Oxford/AstraZeneca coronavirus vaccine for emergency use, the Health Ministry of Ukraine has posted on Facebook.
“Yesterday, February 22, 2021, the Health Ministry of Ukraine registered the Oxford/AstraZeneca COVID-19 vaccine for emergency medical use. The vaccine was developed by the University of Oxford and the British-Swedish company AstraZeneca. The Oxford/AstraZeneca vaccine for emergency use has already been approved by the World Health Organization, and it has been authorized by the United Kingdom, the European Union and India,” the report says.

The Health Ministry notes that the local (trade) name for the Oxford/AstraZeneca vaccine, which is produced at the Serum Institute (India), is Covishield. Respectively, the Covishield vaccine has been officially registered.

As reported, on February 21, Health Minister Maksym Stepanov stated that he had personally supervised the shipment of the first batch of the AstraZeneca vaccine (Covishield) from a manufacturing plant in the Indian city of Pune. The first batch of the vaccine is to arrive in Ukraine on February 23.